212
a
c
b
Fig. 7.1 (a) A 19-year-old male presented with delayed puberty (b) testicular volume of 1 ml with
stretched penile length of 8 cm. Patient is on testosterone therapy. (c) T2W MR image shows nor-
mal olfactory bulb (white arrow) and sulci (red arrow)
clinical and biochemical profile, a diagnosis of congenital idiopathic hypogonado-
tropic hypogonadism (IHH) was considered, and he was initiated with testosterone
enanthate 100 mg intramuscularly every fortnightly. The doses of testosterone were
increased gradually to 200 mg every fortnightly over a period of 2 years. On testos-
terone therapy, he developed gynecomastia. He is planned for gonadotropin therapy
for induction of spermatogenesis after the attainment of virilization (Fig. 7.1).
7 Delayed Puberty